Higher quality colonoscopies reduce colorectal cancer incidence, mortality
the ONA take:
According to a new study published in JAMA, researchers have found that higher adenoma detection rates from colonoscopy screenings may be associated with a lower lifetime colorectal cancer incidence and mortality without increased overall costs.
For the study, researchers sought to estimate the lifetime benefits, complications, and costs of an initial screening program at different levels of adenoma detection by analyzing data from the Kaiser Permanente health care system.
Results showed that among unscreened patients, the lifetime colorectal cancer risk was 34.2% per 1,000 and the lifetime colorectal cancer mortality risk was 13.4% per 1,000. Among those with the highest rates of adenoma detection, the lifetime colorectal cancer risk was 12.5% per 1,000.
In addition, researchers found that despite a higher number of colonoscopies and potential complications, there was no increase in overall costs due to the avoidance of cancer treatment costs.
Higher adenoma detection rates from colonoscopy screenings may be associated with a lower lifetime colorectal cancer incidence.
Sign Up for Free e-newsletters
- Education May Better Equip Nurses to Hold End-of-Life Conversations in Advanced Cancer
- Avoiding the ED: Planned Strategies for Unplanned Urgent Cancer Care
- NP-Led Clinics Improved Phase 1 Oncology Study Operations, Outcomes
- Art as Palliative Care: Bedside Intervention Improves Pain, Anxiety, Mood in Hospitalized Cancer Patients
- Unprotected Sex After Chemotherapy
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|